Health Library

At IsraClinic, with over 20 years of experience in diagnosing and treating complex psychiatric disorders, we apply a unique psychoergonomic and holistic approach developed at our clinic. We conduct diagnostic processes and treatment planning through a multidisciplinary team, including psychiatrists, clinical psychologists, neurologists, and other professionals.

A major study published in JAMA on October 15, 2026, analysed 271 million clinical queries submitted to an artificial intelligence platform by more than 950,000 healthcare professionals. Psychiatrists showed particularly strong interest in medication-related information. Dr. Karny Jabotinsky-Rubin examines what these findings reveal about the growing role of AI in psychiatry, its potential clinical benefits, and the essential safeguards needed to protect patients.

New Israeli research reveals that approximately one in five adults experiences serious difficulties with everyday functioning related to mental health. Dr. Karny Jabotinsky-Rubin, psychiatrist at IsraClinic, examines why improvements in depression, anxiety, and PTSD symptoms do not always lead to full recovery and why restoring daily functioning should be an essential part of psychiatric treatment.

Schizophrenia and schizoaffective disorder are chronic psychiatric conditions characterized by disturbances in thought, perception, and behavior. While pharmacotherapy remains the cornerstone of treatment, there is growing recognition of the importance of integrating non-pharmacological interventions, such as art therapy, to enhance functional outcomes and alleviate symptoms. This article reviews current clinical evidence supporting the use of art therapy as an adjunctive treatment for these disorders.

How does VR therapy help patients with anxiety, PTSD, and ADHD? Valery Kravitz shares practical insights from IsraClinic's integrative psychiatric practice.
Virtual reality in psychiatry opens the door to safe, guided exposure that helps reduce fear and increases a patient’s willingness to engage. It is especially useful for individuals who find traditional therapeutic approaches overwhelming or ineffective.

Some women feel everything too much. Too emotional. Too intense. Too dependent. Too unpredictable. And when the same patterns repeat again and again — in relationships, at work, in family dynamics — there’s a question that begins to echo inside: “Is there something wrong with me?”

By the time many of these women reach my clinic, they’re worn out. They’ve heard from others that they’re “too much,” “unstable,” or “always ruining things.” But in truth? They’re living with Borderline Personality Disorder (BPD) — and no one ever explained it to them.

Artificial intelligence is becoming part of everyday life, including mental health. More and more people now turn to chatbots before speaking to a psychiatrist, psychotherapist, or clinical psychologist. This is easy to understand: it is fast, available at any time, and often feels simpler than arranging a real consultation.

At IsraClinic, we are not against new technologies. Digital tools can be useful when they are used correctly. They may help a person organize symptoms, prepare questions, track mood or sleep, and better understand when it is time to seek professional help.

The problem starts when a chatbot is used instead of a doctor.

In 2025–2026, two major trends became more visible in international psychiatry. The first is a stronger professional push toward earlier and more appropriate use of clozapine in treatment-resistant schizophrenia. The second is the emergence of new non-dopaminergic treatments, especially xanomeline/trospium (Cobenfy), which reflects a broader search for alternative mechanisms in antipsychotic therapy.